DARE-PTB1 not checked

Daré Bioscience, Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
9 active
10 in total · 9 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Each arm will administer different amounts of progesterone vaginally (8mg to 100mg) over a 14-15 day time period.”In the company’s words, NCT06668896 on ClinicalTrials.gov
Tested for
Pre Term Birth
Main trialPhase 1
“This study is looking for healthy female adults to use an vaginal ring with differing amounts of the hormone progesterone and go through a series of blood draws to measure how much progesterone is in the body following the use of these vaginal rings over an extended period of time.”In the company’s words, NCT06668896 on ClinicalTrials.gov
Other names
Progesterone

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials10

TrialPhaseCompletesWhat it tests
Phase 1Not yet recruiting Nov 2027 Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
Phase 4Authorised not given Evaluation of the efficacy of micronized natural progesterone (Seidigestan®) vs GnRH antagonists (Astarté®) in the prevention of LH surge during controlled ovarian stimulation: a randomized clinical trial.
Phase 4Authorised not given Progesterone for prEventing Preterm births in women with PlacEnta pRevia (PEPPER-trial)
Phase 4Authorised not given Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial
Phase 3Authorised not given A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of two formulations of vaginal micronized progesterone.
Phase 4Authorised not given Impact of the presence of the corpus luteum on pregnancies obtained through frozen embryo transfer(FET): a prospective randomizedcontrolled study
Phase 2Ended not given Exploratory study on the impact of different doses and route of administration of exogenous progesterone in artificial endometrial preparation cycles on endometrial structure and function
Phase 4Authorised not given Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer
Phase 4Authorised not given Exogenous progesterone as ovulation trigger – a pilot study
Phase 4Authorised not given Luteal phase support following letrozole treatment in women undergoing intrauterine insemination: a multicenter randomized trial
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow DARE-PTB1

Following is part of Solo: you see every change to DARE-PTB1 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in